• Warning icon
    Event has a status of Closed

Drug-Device Combinations and Other Technologies

Drug-Device Combinations and Other Technologies
Module 18 of the MSc (Medical Devices) and Masterclass: This module will enable you to consider and evaluate the practical regulatory aspects including the design, development and lifecycle of a medical device product.
When: 3-5 September 2018
Where: TOPRA Office, 6th Floor, 3 Harbour Exchange, London, E14 9GE
Start time (Day 1):  13:00
End time (Day 3):  16:00

Course focus

This course will look at the manufacture of medical devices when using innovative manufacturing techniques, for example 3-D printing, and other areas of special interest, such as drug-device combinations, borderline products and tissue engineering. Delegates will explore and critically debate the regulatory issues likely to arise from the manufacturing of medical devices with such techniques, in order to be able to provide effective management and advice on the placement of such products on the market.

The module will also cover the application of legislation, directives, guidelines, interpretation and classification documents and regulatory requirements revolving around medical devices manufactured with innovative/non-traditional processes including drug-device, combination and borderline products. It will also include specific information on Notified Body and Competent Authority, special  requirements such as human factor testing, quality by design, risk analysis and management of such devices. Where possible, case studies will be used to achieve those learning goals and put into practice the theory behind the relative legislation.

Who is it for?

This module is designed for regulatory affairs professionals interested or working with medical devices manufactured with innovative/non-traditional processes and/or falling within the classification of drug-device, combination and/or borderline products. The course is suitable for anyone working in medical devices or individuals involved or interested in this area and students completing their MSc in regulatory affairs. 


What will I learn?


Knowledge and understanding:

  • Understand and be able to manage successfully the application of regulatory requirements and relevant legislation, including required documentation for the purpose of placing medical devices and drug-device combination products on the market. In particular, critical analysis of the further requirements related to innovative manufacturing processes
  • Recommend strategies for development and marketing of medical devices manufactured with innovative/non-traditional processes
  • Demonstrate critical understanding of issues related to requirements dictated by applicable legislation over and above the medical device regulations
  • Judge appropriate regulatory strategies for drug-device combination and borderline products.

Skills and attributes:

  • Demonstrate the ability to interpret, analyse and put into practice current legislation applicable to medical devices manufactured with innovative/non-traditional processes
  • be able to make sound judgements of complex issues and deliver strategic solutions and conclusions that can realistically be applied in practice
  • Critically appraise and evaluate communications form regulatory bodies and research publications regarding medical devices manufactured with innovative/non-traditional processes.

Download the course programme

CPD credit: 20
To learn about why CPD is important visit the Lifelong Learning page

About the Module Leader

Jason CollinsJason Collins MTOPRA, has more than 17 years of experience in Regulatory Affairs from industry and consultancy. He recently joined ESPL Regulatory Consulting as Associate Director, Regulatory Affairs.

Previously he was a consultant at regulatory affairs consultancy RRG, where he provided support to clients across a variety of regulatory activities involving both medicines and medical devices, including clinical development, scientific advice (EMA, FDA and EU national) and Regulatory Agency negotiation, right the way through to product authorisation and lifecycle management.

Jason has been responsible for preparation and submission of briefing documents (to support Scientific Advice Meetings), documentation for CTAs, including IBs and IMPDs, as well as preparation of documentation and management of EU MAA submissions (including national and DCP submissions) and US NDAs and INDs. Jason was also the Quality Manager at RRG, responsible for the Quality Management System (QMS), including reviewing, updating, maintaining and training staff on the quality procedures, and managing external contractors. He was also responsible for managing patient information leaflet user testing, and has conducted numerous user tests which have supported national, decentralised and centralised applications in the EU.

How do I register? 

Course fees:
Type Student Non-Student
Standard    £1500+VAT £1700+VAT 

Discounted places
A limited number of discounted places are available for those working for regulatory agencies, government bodies, charities or patient groups. Please email us for a discount code before making your booking.


Terms and conditions 

Please read the training terms and conditions before booking this course. By booking a place on this course you are agreeing to the training terms and conditions 

Travel and accommodation is not included. 

03/09/2018 13:00 - 05/09/2018 16:00
TOPRA Office 6th Floor 3 Harbour Exchange South Quay London E14 9EG UNITED KINGDOM
Online registration not available.
Your VAT country
Your Vat number
If your company VAT number does not appear here or you would like to be invoiced using a different VAT number please email finance@topra.org

Register now